ChemicalBook

204318-14-9(DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)) Product Description

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Structure204318-14-9
CAS No.204318-14-9
Chemical Name:DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
CBNumber:CB2293419
Molecular Formula:C65H92N14O18S2
Formula Weight:1421.65
MOL File:Mol file
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Synonyms:
DOTA-[TYR3]-OCTREOTIDE
DOTATOC
DOTA-FCYWKTCT-OL (DISULFIDE BRIDGE: 2-7)
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
[DOTA-DPHE1, TYR3]OCTREOTIDE
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THREONINOL
EDOTREOTIDE
4,7,10-TRICARBOXYMETHYL-1,4,7,10-TETRAAZA-CYCLODODECAN-1-YL-ACETYL-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND)

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Property

alpha  22D -14.75° (c = 0.52 in 95% acetic acid)
Boiling point: 1723.7±65.0 °C(Predicted)
Density  1.46±0.1 g/cm3(Predicted)
pka 1.83±0.10(Predicted)
form  Solid
color  White to off-white
Sequence DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7)

Safety

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Suppliers

Global( 84)Suppliers     
SupplierTelEmailCountryProdListAdvantage
Nanchang Tianzhen Biotechnology Co., Ltd  pomy@tanzhenbio.comChina 1779 58
Hangzhou Beiputai Biopharmaceutical Co., Ltd 0571-85350119bptsales@163.comChina 3850 58
Alfa Chemistry  Info@alfa-chemistry.comUnited States 24072 58
Watson Biotechnology Co.,Ltd +86-18186686046sales01@watsonbiotech.cnChina 5863 58
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303Caroline@youngshechem.comChina 4900 58
Hubei Moco Chemical Co., Ltd.  3001071511@qq.comChina 10986 58
Molcoo Chemicals Inc.  3001051413@qq.comChina 9249 58
Hubei wei shi reagent group ltd., company 027-027591017662853877621@qq.comChina 4214 58
204318-14-9(DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)) Related Search:
DOTA-[TYR3]-OCTREOTIDE DOTATOC DOTA-FCYWKTCT-OL (DISULFIDE BRIDGE: 2-7) DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) [DOTA-DPHE1, TYR3]OCTREOTIDE DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THREONINOL EDOTREOTIDE 4,7,10-TRICARBOXYMETHYL-1,4,7,10-TETRAAZA-CYCLODODECAN-1-YL-ACETYL-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND) DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7) EDOTREOTIDUM L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-Lthreonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2)-disulfide DOTA-TOC204318-14-9 2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide SMT 487 SMT487 SMT-487 somatostatin,DOTATOC,Edotreotide,inhibit,cancer,Inhibitor,radionuclides,SDZ-SMT 487 DOTA-(Tyr3)-Octreotide acetate salt DOTA-(Tyr?)-Octreotide acetate salt NOTA-TOC DOTA-[Tyr3]Octreotide, DOTA-TOC, Edotreotide 204318-14-9 C65H92N14O18S2 peptide
Copyright 2017 © ChemicalBook. All rights reserved